Back to BMY Stock Lookup

BMY Related Analyst Ratings

May 16, 2013 01:55 PM UPDATE: Leerink Swann Upgrades Bristol-Myers Squibb Co. (BMY) to Outperform

May 16, 2013 07:57 AM Goldman Sees Blockbuster Potential for Bristol-Myers Squibb's (BMY) Nivolumab (PD-1)

May 15, 2013 10:53 AM Bristol-Myers Squibb Company (BMY) Moves Higher Ahead of ASCO Presscast / Abstracts

Apr 10, 2013 08:30 AM Jefferies Lifts PT on Pharmaceuticals Stocks (ABBV) (NVS) (SNY) (PFE)

Apr 1, 2013 11:47 AM Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation

Apr 1, 2013 09:37 AM ICON (ICLR) on Watch as Bristol-Myers Squibb (BMY) Adds New Lab Provider

Mar 5, 2013 04:39 PM William Blair Starts Bristol-Myers Squibb Co. (BMY) at Outperform

Mar 4, 2013 07:04 AM BofA/Merrill Lynch Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral

Feb 12, 2013 01:15 PM Bristol-Myers' Baraclude News Could Be Positive for Teva Pharma (TEVA) - Analyst

Dec 31, 2012 08:34 AM Atlantic Equities Upgrades Bristol-Myers Squibb Co. (BMY) to Neutral

Nov 30, 2012 06:51 AM Citi Starts Bristol-Myers Squibb Co. (BMY) at Neutral

Nov 12, 2012 07:19 AM BMO Capital Downgrades Bristol-Myers Squibb Co. (BMY) to Market Perform

Oct 4, 2012 03:17 PM NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst

Sep 11, 2012 08:17 AM Credit Suisse Starts Bristol-Myers Squibb Co. (BMY) at Neutral

Sep 11, 2012 07:06 AM Goldman Sachs Upgrades Bristol-Myers Squibb Co. (BMY) to Conviction Buy

Aug 30, 2012 10:50 AM UBS Reiterates a 'Buy' on Gilead Sciences (GILD); Raises Numbers on Favorite Large-Cap Biotech

Aug 28, 2012 03:42 PM Barclays on U.S. Biopharmaceuticals: Fate of Nucs Under Harsh Scrutiny - More Angst for IDIX; GILD Widens Lead

Aug 24, 2012 07:58 AM BofA/Merrill Lynch Upgrades Bristol-Myers Squibb Co. (BMY) to Buy

Aug 20, 2012 11:03 AM Amarin (AMRN) NCE Status Could Happen by September 14 and Takeover Could Follow - MKM

Aug 17, 2012 02:54 PM Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)

Aug 17, 2012 08:46 AM Leerink Swann maintains an 'Outperform' on Idenix Pharmaceuticals (IDIX); Clinical Hold Feels More Like Precaution

Aug 6, 2012 07:29 AM Buy Bristol-Myers (BMY) On Weakness - Jefferies

Aug 2, 2012 01:44 PM UBS on Bristol-Myers Squibb's (BMY) INX-189 Stumble: At Best Puts Bristol Behind; At Worst, Out of the Race

Aug 2, 2012 10:22 AM Barclays Downgrades Bristol-Myers Squibb Co. (BMY) to Equalweight

Aug 2, 2012 08:37 AM Nomura Securities Reiterates a 'Reduce' on AstraZeneca (AZN); Overpayment Risk in Deal with Bristol Myers (BMY)

Jul 20, 2012 03:23 PM UBS Maintains a 'Neutral' on Bristol-Myers Squibb Co. (BMY); Brivanib Misses in HCC

Jul 20, 2012 08:44 AM UPDATE: Onyx Pharma (ONXX) Shares Rise as Leerink Swann Upgrades to Outperform

Jul 16, 2012 09:49 AM S&P 500 (SPY) is Going Higher Because Analyst Carter Worth Says So

Jul 13, 2012 08:32 AM Jefferies on Pharmaceuticals: Global Pharmaceuticals Q2'12 Earnings Preview; Where is it Safe to Hide?

Jul 2, 2012 03:10 PM Barclays on AstraZeneca (AZN): Acquisition of AMLN Makes Strategic Sense but High Price Tag

Jun 26, 2012 08:36 AM Citi Says Buy the Dip in Bristol-Myers (BMY) Shares

Jun 15, 2012 09:09 AM Amylin (AMLN) Wants a Buyout Price At Least in the Low-to-Mid $30s - Jefferies

Jun 7, 2012 11:00 AM UBS Maintains a 'Neutral' on Bristol-Myers Squibb Co. (BMY); Orencia Data May Lead To Market Share Gains

Jun 4, 2012 10:24 AM Goldman Sachs Maintains Bullish Stance on Bristol-Myers (BMY) Following ASCO

May 25, 2012 01:40 PM Barclays Remains Bullish on Vertex (VRTX); Upside to Phase I Data

May 18, 2012 08:18 AM BMO Capital Starts Bristol-Myers Squibb Co. (BMY) at Outperform

May 11, 2012 01:26 PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium

May 2, 2012 08:38 AM Goldman Sachs Maintains Top Rating on Pfizer (PFE), Catalysts Ahead and Possible Full Break-Up

Apr 23, 2012 01:21 PM Brean Murray Carret & Co. maintains a 'Buy' on Achillion Pharmaceuticals (ACHN); Removes From N-T Focus List, But Dip Offers Investor Opportunity

Apr 19, 2012 03:17 PM Brean Murray Carret & Co. Out In Defense of Achillion Pharmaceuticals (ACHN); Superficial Read-Through

Apr 19, 2012 10:40 AM Needham & Company Reiterates a 'Buy' on Gilead Sciences (GILD) on Positive Interim Data from GS7977 Trials

Mar 28, 2012 12:35 PM Analysts Expecting Higher Bids for Amylin (AMLN)

Mar 28, 2012 11:06 AM Baird Comments on Amylin (AMLN) On Takeover Speculation

Mar 1, 2012 09:07 AM VIVUS (VVUS) Could Be Bought For Up to $40/Share

Feb 7, 2012 11:38 AM Achillion (ACHN) Shares Rocked as BofA Cuts to Underperform

Jan 30, 2012 01:17 PM Q4 Preview: Pfizer (PFE) May Suffer Same Ailment as Peers: Strong Dollar Syndrome

Jan 30, 2012 07:31 AM Jefferies Maintains a 'Buy' on Bristol-Myers Squibb (BMY); Growth Drivers Exceed Expectations

Jan 19, 2012 10:18 AM Bristol-Myers (BMY) Shares Continuing Lower as Morgan Stanley Cuts to Equalweight

Jan 9, 2012 03:24 PM JMP Cuts Idenix (IDIX) to Market Underperform, Sets $4 Price Target

Jan 9, 2012 10:36 AM Wall Street Hot and Bothered About Idenix (IDIX) and Achillion (ACHN) After INHX/BMY Deal

Back to BMY Stock Lookup